Ann: Cyclopharm to Proceed Independently with FDA Trials-CYC.AX, page-28

I admit there definite differences between the 2 business but is it like comparing an ultrasound to a CAT scan?
RAP claim a pretty high success rate at diagnosing lung disorders. Isn't that what CYC claims to do also? Diagnose lung issues?
Maybe RAP's technology would be a cheap first step to diagnosis then nuclear medicine such as Technegas could be used for a clearer picture - ie 3D scan to assess the extent of the lung damage?

True RAP have no revenue or dividends. They are looking to have FDA approval by Q4.

Don't get me wrong, I'm a fan of both businesses, I'm just having a discussion as they both target lung disorders.